Navigation Links
XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)
Date:12/20/2007

VENICE, Fla., Aug. 10 /PRNewswire/ -- XCPT, LLC has entered into a representation agreement with Lifecore Biomedical, Inc. to market its products to dentists throughout the world.

XCPT's software is a highly graphic, face-to-face, patient consultation and engagement method recognizing the importance of visual learning during treatment planning. With XCPT, the patient is involved in every step of the dental treatment process as the clinician uses the patient's own x-rays, CT scans and/or photographs to communicate treatment options and solutions. "XCPT's software helps patients decide what is best for them in a trusting, open environment," says Dr. Steven J. Feldman, CEO of XCPT. "With its use, we're seeing doctors gain productivity and increased case acceptance by simply showing the patient what they see."

The signing of the agreement reinforces XCPT's ongoing strategy to be the patient engagement and communication software of choice for the leading implant manufacturers, dental schools and dental practices throughout the country. The agreement with Lifecore marks the third dental implant company and seventh company overall which has begun to incorporate XCPT as a practice- building tool throughout their salesforce.

"We're honored and pleased to have forged this agreement with Lifecore," said Dr. Feldman. "From the time of our first meeting with Lifecore, we were excited about the prospects of becoming integrated into their sales and education curriculum. We see the natural fit between our software's communication capabilities and Lifecore's ability to market implants worldwide."

Speaking on behalf of Lifecore Dental, a Division of Lifecore Biomedical, John DeAngelo, Marketing Portfolio Manager, said, "There are four steps to pre-surgical treatment planning: 1. patient expectations, 2. prosthetic options, 3. biomechanical principles and 4. the team approach which involves the surgeon, restoring dentist and the laboratory. XCPT provides the clinician and their patients a predictable environment for planning all aspects of the implant reconstruction. It allows the doctor to make the important decisions on treatment planning and allows for clear communication between the treatment team and the patient. Finally, it provides patient confidence knowing that a team worked together for an optimal outcome."

To reach a Lifecore sales representative in your area, call 1-800-752- 2663.

For more information or to download the FREE full version 30-day trial, call XCPT at 866.927.9278 or visit http://www.xcpt.com

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LCBM) in business over 40 years, develops, manufactures and markets biomaterials and medical devices for use in various surgical markets through two divisions, the Dental Division and the Hyaluronan Division. The Dental Division conducts its dental surgery business through direct sales and marketing in the United States, France, Germany, Italy and Sweden and through distributors in 49 other countries. The Hyaluronan Division conducts its business through OEM and contract manufacturing alliances in the ophthalmic, orthopedic and veterinary surgical fields.

General Corporate Information is available on the internet at http://www.lifecore.com

About XCPT, LLC

XCPT's Patient Engagement and Communication software was developed to provide an innovative communication method for patients and their healthcare professionals. With its adoption, communication becomes clearer for dental teams in their relationships with patients, their team members, and their referral networks.


'/>"/>
SOURCE XCPT, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 26, 2017 , ... After raising nearly $30,000 on Kickstarter , about ... available at a discounted crowdfunding price on Indiegogo . , “Along with creating ... wanted to bring a fidget toy to the market that was made of superior ...
(Date:5/26/2017)... ... 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in wisdom ... on insurance options. If a Bay Area patient has to search for a second ... Visiting an in-network provider for a second opinion can ensure a patient receives the ...
(Date:5/26/2017)... ... ... in the Garden of Eden”: retells the stories of three Bible figures in modern terms. ... Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. Born in ... six, they moved to Dayton, Ohio, where Penny graduated high school. At sixteen, she ...
(Date:5/24/2017)... ... May 24, 2017 , ... In modern ... the most appropriate instruments for research and understanding the basic principles that were ... will focus on innovations in stereo microscopy for brightfield and fluorescence typically used ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... dental implants in Bayside, NY, who have now spent 10 years as clinical ... New York University (NYU) College of Dentistry. Through the program, private practitioners receive ...
Breaking Medicine News(10 mins):
(Date:5/24/2017)... 24, 2017  ivWatch LLC today announced the ... Board to enable seamless integration of ivWatch,s groundbreaking ... infusion pumps and other devices. By integrating ivWatch ... to help health care customers deliver a higher ... to IV therapy. "The ivWatch OEM ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/10/2017)... MARLBOROUGH, Mass., May 10, 2017 Hologic, Inc. ... financial results for the fiscal second quarter ended April ... (EPS) of $1.84 increased 666.7% compared to the prior ... business resulted in a significant gain, while non-GAAP diluted ... increased 3.2%, or 3.8% in constant currency terms.  Excluding ...
Breaking Medicine Technology: